Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Early life adversity blunts responses to pioglitazone in depressed, overweight adults.

Robakis TK, Watson-Lin K, Wroolie TE, Myoraku A, Nasca C, Bigio B, McEwen B, Rasgon NL.

Eur Psychiatry. 2018 Oct 29;55:4-9. doi: 10.1016/j.eurpsy.2018.09.009. [Epub ahead of print]

PMID:
30384111
2.

An emerging epigenetic framework of systemic and central mechanisms underlying stress-related disorders.

Nasca C, Rasgon N, McEwen B.

Neuropsychopharmacology. 2019 Jan;44(1):235-236. doi: 10.1038/s41386-018-0227-1. No abstract available.

3.

Acetyl-l-carnitine deficiency in patients with major depressive disorder.

Nasca C, Bigio B, Lee FS, Young SP, Kautz MM, Albright A, Beasley J, Millington DS, Mathé AA, Kocsis JH, Murrough JW, McEwen BS, Rasgon N.

Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):8627-8632. doi: 10.1073/pnas.1801609115. Epub 2018 Jul 30.

PMID:
30061399
4.

Insulin resistance, an unmasked culprit in depressive disorders: Promises for interventions.

Watson K, Nasca C, Aasly L, McEwen B, Rasgon N.

Neuropharmacology. 2018 Jul 1;136(Pt B):327-334. doi: 10.1016/j.neuropharm.2017.11.038. Epub 2017 Nov 26. Review.

PMID:
29180223
5.

Role of the Astroglial Glutamate Exchanger xCT in Ventral Hippocampus in Resilience to Stress.

Nasca C, Bigio B, Zelli D, de Angelis P, Lau T, Okamoto M, Soya H, Ni J, Brichta L, Greengard P, Neve RL, Lee FS, McEwen BS.

Neuron. 2017 Oct 11;96(2):402-413.e5. doi: 10.1016/j.neuron.2017.09.020.

6.

Reply to Arduini et al.: Acetyl-l-carnitine and the brain: Epigenetics, energetics, and stress.

Bigio B, Nasca C, McEwen BS.

Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):E5700-1. doi: 10.1073/pnas.1612347113. Epub 2016 Sep 12. No abstract available.

7.

Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance.

Bigio B, Mathé AA, Sousa VC, Zelli D, Svenningsson P, McEwen BS, Nasca C.

Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7906-11. doi: 10.1073/pnas.1603111113. Epub 2016 Jun 27.

8.

Stress-induced structural plasticity of medial amygdala stellate neurons and rapid prevention by a candidate antidepressant.

Lau T, Bigio B, Zelli D, McEwen BS, Nasca C.

Mol Psychiatry. 2017 Feb;22(2):227-234. doi: 10.1038/mp.2016.68. Epub 2016 May 31.

9.

Mitochondrial functions modulate neuroendocrine, metabolic, inflammatory, and transcriptional responses to acute psychological stress.

Picard M, McManus MJ, Gray JD, Nasca C, Moffat C, Kopinski PK, Seifert EL, McEwen BS, Wallace DC.

Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):E6614-23. doi: 10.1073/pnas.1515733112. Epub 2015 Nov 16.

10.

Stress dynamically regulates behavior and glutamatergic gene expression in hippocampus by opening a window of epigenetic plasticity.

Nasca C, Zelli D, Bigio B, Piccinin S, Scaccianoce S, Nisticò R, McEwen BS.

Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14960-5. doi: 10.1073/pnas.1516016112. Epub 2015 Nov 16.

11.

Mechanisms of stress in the brain.

McEwen BS, Bowles NP, Gray JD, Hill MN, Hunter RG, Karatsoreos IN, Nasca C.

Nat Neurosci. 2015 Oct;18(10):1353-63. doi: 10.1038/nn.4086. Epub 2015 Sep 25. Review.

12.

Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex.

McEwen BS, Nasca C, Gray JD.

Neuropsychopharmacology. 2016 Jan;41(1):3-23. doi: 10.1038/npp.2015.171. Epub 2015 Jun 16. Review.

13.

60 YEARS OF NEUROENDOCRINOLOGY: Redefining neuroendocrinology: stress, sex and cognitive and emotional regulation.

McEwen BS, Gray JD, Nasca C.

J Endocrinol. 2015 Aug;226(2):T67-83. doi: 10.1530/JOE-15-0121. Epub 2015 May 1. Review.

14.

Recognizing Resilience: Learning from the Effects of Stress on the Brain.

McEwen BS, Gray J, Nasca C.

Neurobiol Stress. 2015 Jan 1;1:1-11.

15.

Mind the gap: glucocorticoids modulate hippocampal glutamate tone underlying individual differences in stress susceptibility.

Nasca C, Bigio B, Zelli D, Nicoletti F, McEwen BS.

Mol Psychiatry. 2015 Jun;20(6):755-63. doi: 10.1038/mp.2014.96. Epub 2014 Sep 2.

16.

Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.

di Nuzzo L, Orlando R, Nasca C, Nicoletti F.

Drug Des Devel Ther. 2014 May 19;8:555-68. doi: 10.2147/DDDT.S52428. eCollection 2014. Review.

17.

The presence of depressive symptoms in comorbidity with Alzheimer's disease does not influence changes in serum brain-derived neurotrophic factor levels in older patients.

Curto M, Martocchia A, Comite F, Scaccianoce S, Xenos D, Nasca C, Ferracuti S, Girardi P, Nicoletti F, Falaschi P.

Int J Geriatr Psychiatry. 2014 Apr;29(4):439-40. doi: 10.1002/gps.4067. No abstract available.

PMID:
24599735
18.

A novel computational biostatistics approach implies impaired dephosphorylation of growth factor receptors as associated with severity of autism.

Wittkowski KM, Sonakya V, Bigio B, Tonn MK, Shic F, Ascano M, Nasca C, Gold-Von Simson G.

Transl Psychiatry. 2014 Jan 28;4:e354. doi: 10.1038/tp.2013.124.

19.

Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report.

Martocchia A, Curto M, Scaccianoce S, Comite F, Xenos D, Nasca C, Falaschi GM, Ferracuti S, Girardi P, Nicoletti F, Falaschi P.

Aging Clin Exp Res. 2014 Aug;26(4):461-4. doi: 10.1007/s40520-014-0194-2. Epub 2014 Jan 17.

PMID:
24435333
20.

L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.

Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F, Battaglia G, Mathé AA, Pittaluga A, Lionetto L, Simmaco M, Nicoletti F.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4804-9. doi: 10.1073/pnas.1216100110. Epub 2013 Feb 4.

Supplemental Content

Support Center